Page last updated: 2024-10-29

ketamine and Fatty Liver

ketamine has been researched along with Fatty Liver in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schaps, D1
Hauenschild, E1

Other Studies

1 other study available for ketamine and Fatty Liver

ArticleYear
[The use of ketamine in patients with liver damage (author's transl)].
    Der Anaesthesist, 1977, Volume: 26, Issue:4

    Topics: Anesthesia; Blood Pressure; Droperidol; Fatty Liver; Heart Rate; Hepatitis; Humans; Jaundice; Ketami

1977